Healthcare - Biotechnology - NASDAQ - US
$ 0.1901
-2.51 %
$ 40.2 M
Market Cap
None
P/E
INCOME STATEMENT
0
REVENUE
-24.3 M
OPERATING INCOME
-24.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Reviva Pharmaceuticals Holdings, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 24.3 M |
| Operating Income | -24.3 M |
| Other Expenses | 32.7 K |
| Net Income | -24.3 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Feb-2020 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 0 | 0 | 0.7 | 0 |
| Gross Profit | 0 | 0 | (0.7) | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 24.3 | 10.1 | 2.4 | 0.4 |
| Selling, General and Administrative Expenses | 5.4 | 5.3 | 2.1 | 0.2 |
| Research and Development Expenses | 18.9 | 4.9 | 0.3 | 0.2 |
| Operating Income | (24.3) | (10.1) | (2.4) | (0.4) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 0.2 | 2.41 K | 1.5 | 0.5 |
| Total Other Income | 11.9 K | 1.6 | (1.3) | (0.5) |
| Pre-Tax Income | (24.3) | (8.5) | (3.8) | (0.8) |
| NET INCOME | ||||
| Tax Provision | 20.8 K | 6 K | 800 | 800 |
| Net Income | (24.3) | (8.5) | (3.8) | (0.8) |
| EPS | 1.25 | 0.58 | 1.24 | 0.31 |